Caricamento...

Imatinib improves insulin resistance and inhibits injury-induced neointimal hyperplasia in high fat diet-fed mice

Imatinib, a PDGF receptor tyrosine kinase inhibitor, has been shown to suppress intimal hyperplasia in different animal models under normal metabolic milieu, diabetic, and/or hypercholesterolemic conditions. However, the impact of imatinib treatment on injury-induced neointimal hyperplasia has not y...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur J Pharmacol
Autori principali: Pichavaram, Prahalathan, Shawky, Noha M., Hartney, Thomas J., Jun, John Y., Segar, Lakshman
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7749815/
https://ncbi.nlm.nih.gov/pubmed/33131722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2020.173666
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !